I don't even disagree with you. They should have performed infinitely better than they have. It's poor management, but a pull form the market can negate even the most incompetent management. That's what happened with A2M. They produced a product the market (in China) loved at a time when confidence in their domestic brand was virtually 0. I had over $40,000 in A2M at just over 40c and sold out a couple of years ago between $12 - $14. It was a similar thing to this. Crap management, decent products. It may not play out the same here, but let's see. You don't win or lose until you hit the sell button.
HCT Price at posting:
5.2¢ Sentiment: Hold Disclosure: Held
